182 related articles for article (PubMed ID: 16019554)
1. Immunoglobulin D myeloma--problems with diagnosing and staging (own experience and literature review).
Kuliszkiewicz-Janus M; Zimny A; Sokolska V; Saşiadek M; Kuliczkowski K
Leuk Lymphoma; 2005 Jul; 46(7):1029-37. PubMed ID: 16019554
[TBL] [Abstract][Full Text] [Related]
2. IgD myeloma: clinical characteristics and a new staging system based on analysis of Japanese patients.
Shimamoto Y
Cancer Detect Prev; 1995; 19(5):426-35. PubMed ID: 7585729
[TBL] [Abstract][Full Text] [Related]
3. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
[TBL] [Abstract][Full Text] [Related]
4. IgD multiple myeloma. Review of 133 cases.
Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
[TBL] [Abstract][Full Text] [Related]
5. Immunodiagnosis of IgD multiple myeloma. A report of 17 cases.
Chernokhvostova EV; Batalova TN; German GP; Andreyeva NE
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):539-52. PubMed ID: 6170548
[TBL] [Abstract][Full Text] [Related]
6. Unusual myelomas: a review of IgD and IgE variants.
Pandey S; Kyle RA
Oncology (Williston Park); 2013 Aug; 27(8):798-803. PubMed ID: 24133829
[TBL] [Abstract][Full Text] [Related]
7. [IgD myeloma manifesting as acute renal insufficiency].
Duvic C; Sarret D; De Revel T; Hérody M; Didelot F; Labaye J; Nédélec G
Rev Med Interne; 2000 Sep; 21(9):799-803. PubMed ID: 11039177
[TBL] [Abstract][Full Text] [Related]
8. [IgD multiple myeloma mimicking free light chain myeloma complicated by factor X deficiency: a case report].
Lasri N; Lahlimi F; Tazi MI; Rigaudeau S
Pan Afr Med J; 2022; 41():338. PubMed ID: 35865841
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin D multiple myeloma.
Lin TL; Shih LY; Dunn P; Wang PN; Wu JH; Kao MC
Chang Gung Med J; 2000 Aug; 23(8):451-7. PubMed ID: 11039246
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in IgD myeloma: a study of 21 cases.
Fibbe WE; Jansen J
Scand J Haematol; 1984 Nov; 33(5):471-5. PubMed ID: 6515330
[TBL] [Abstract][Full Text] [Related]
11. IgD-λ multiple myeloma with excessive excretion of free light chains: a diagnostic trap in the identification of monoclonal gammopathies.
Zahir H; Tali A; Rachidi M; Mouhib H; Daif H; Ait Ouzdi Z; Haouach K; Chabaa L
Ann Biol Clin (Paris); 2019 Feb; 77(1):107-111. PubMed ID: 30799291
[TBL] [Abstract][Full Text] [Related]
12. A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients.
Shimamoto Y; Anami Y; Yamaguchi M
Eur J Haematol; 1991 Oct; 47(4):262-7. PubMed ID: 1954984
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognosis of immunoglobulin D myeloma in the novel agent era.
Chen L; Fan F; Deng J; Xu J; Xu A; Sun C; Hu Y
Ann Hematol; 2019 Apr; 98(4):963-970. PubMed ID: 30610280
[TBL] [Abstract][Full Text] [Related]
14. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia.
Bladé J; Kyle RA
Hematol Oncol Clin North Am; 1999 Dec; 13(6):1259-72. PubMed ID: 10626149
[TBL] [Abstract][Full Text] [Related]
15. IgD multiple myeloma with renal involvement: case report.
Homan H; Ohtubo Y; Ito H; Azuma K; Yasumoto Y; Ohtuka H; Uomizu K; Yamashita W; Uemura S; Ohsaki K
Jpn J Med; 1990; 29(2):212-5. PubMed ID: 2232370
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.
Zagouri F; Kastritis E; Symeonidis AS; Giannakoulas N; Katodritou E; Delimpasi S; Repousis P; Terpos E; Dimopoulos MA;
Eur J Haematol; 2014 Apr; 92(4):308-12. PubMed ID: 24460646
[TBL] [Abstract][Full Text] [Related]
17. N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma.
Chen J; Fang M; Chen X; Yi C; Ji J; Cheng C; Wang M; Gu X; Sun Q; Gao C
BMC Cancer; 2017 Dec; 17(1):881. PubMed ID: 29268706
[TBL] [Abstract][Full Text] [Related]
18. [An elderly patient with IgD myeloma associated with renal amyloidosis and acute renal failure].
Kiyatake I; Tomino Y; Funabiki K; Kubokawa Y; Shirato I; Kubota M; Koide H
Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):791-6. PubMed ID: 2511365
[TBL] [Abstract][Full Text] [Related]
19. More frequent IgD and reduced CD200 expression in Chinese patients younger than 50 years old with multiple myeloma: a multicenter analysis.
Lu J; Lu J; Chen W; Wang J; Huo Y; Hou J; Huang X
Drug Des Devel Ther; 2016; 10():3673-3679. PubMed ID: 27877018
[TBL] [Abstract][Full Text] [Related]
20. An unusual case of myeloma. Non-secretory IgD-kappa myeloma with de-differentiation of kappa myeloma evolving from solitary plasmocytoma.
Nelis GF
Acta Med Scand; 1982; 211(1-2):141-4. PubMed ID: 6803520
[No Abstract] [Full Text] [Related]
[Next] [New Search]
